Every record from Janoshik · page 63
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2024-004561 | Semaglutide | JEEP | JEEP-2405-D3060 | 2024-Q4 | 98.49 | 5.33 | 94.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004416 | CJC-1295 (no DAC) | QSC | QSC-2410-L8549 | 2024-Q4 | 98.21 | 6.65 | 101.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005547 | Tirzepatide | QST | QST-2409-K8302 | 2024-Q4 | 98.65 | 6.83 | 97.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005262 | TB-500 | SSA | SSA-2406-H7478 | 2024-Q4 | 98.40 | 5.32 | — | Laboratory-retained | 3 | FAIL |
| AX-2024-005414 | BPC-157 | WXT | WXT-2410-J4489 | 2024-Q4 | 98.02 | 4.94 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005236 | Mazdutide | SSA | SSA-2407-L6907 | 2024-Q4 | 97.75 | 4.26 | 106.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005107 | BPC-157 | KP | KP-2407-L4230 | 2024-Q4 | 98.40 | 2.31 | 95.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004974 | Cagrilintide | GGPeps | GGPE-2410-U9081 | 2024-Q4 | 98.59 | 5.23 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004808 | SS-31 (Elamipretide) | Homopeptide | HOMO-2410-K1981 | 2024-Q4 | 99.93 | 4.21 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005427 | MK-677 (Ibutamoren mesylate) | WXT | WXT-2408-P5247 | 2024-Q4 | 99.43 | 5.03 | 93.9 | Supplier-supplied | 2 | FAIL |
| AX-2024-004137 | Afamelanotide | WWB | WWB-2406-Y1595 | 2024-Q4 | 99.54 | 4.34 | 94.1 | Supplier-supplied | 0 | PASS |
| AX-2024-005548 | Tirzepatide | QST | QST-2409-K8302 | 2024-Q4 | 98.26 | 6.11 | 95.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004458 | MOTS-c | FGP | FGP-2411-A1460 | 2024-Q4 | 99.63 | 4.75 | 101.5 | Supplier-supplied | 0 | PASS |
| AX-2024-004692 | MGF | TFC | TFC-2408-M8176 | 2024-Q4 | 99.59 | 3.11 | — | Laboratory-retained | 0 | PASS |
| AX-2024-005030 | Semaglutide | GGPeps | GGPE-2410-L1879 | 2024-Q4 | 98.77 | 3.90 | 91.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004585 | MK-677 (Ibutamoren mesylate) | JEEP | JEEP-2406-M4461 | 2024-Q4 | 99.61 | 4.14 | — | Supplier-supplied | 1 | FAIL |
| AX-2024-004269 | GHRP-6 | QYB | QYB-2410-S5114 | 2024-Q4 | 99.49 | 6.29 | 102.0 | Supplier-supplied | 2 | FAIL |
| AX-2024-005106 | BPC-157 | KP | KP-2407-L4230 | 2024-Q4 | 98.93 | 1.97 | 95.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004753 | PT-141 (Bremelanotide) | Homopeptide | HOMO-2408-P9247 | 2024-Q4 | 99.31 | 2.17 | 95.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004176 | Semaglutide | WWB | WWB-2410-D2737 | 2024-Q4 | 99.49 | 0.87 | — | Supplier-supplied | 0 | PASS |
| AX-2024-005108 | BPC-157 | KP | KP-2407-L4230 | 2024-Q4 | 98.48 | 2.21 | 104.3 | Laboratory-retained | 1 | MARGINAL |
| AX-2024-004524 | Ipamorelin | FGP | FGP-2409-T2292 | 2024-Q4 | 99.91 | 4.41 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004522 | Ipamorelin | FGP | FGP-2409-T2292 | 2024-Q4 | 99.29 | 5.05 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004210 | Survodutide | WWB | WWB-2408-T3710 | 2024-Q4 | 99.32 | 2.56 | 100.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004651 | Retatrutide | TFC | TFC-2409-H7264 | 2024-Q4 | 97.62 | 4.50 | 96.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004957 | Retatrutide | GGPeps | GGPE-2411-R7895 | 2024-Q4 | 99.25 | 5.62 | 96.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004693 | MGF | TFC | TFC-2408-M8176 | 2024-Q4 | 99.45 | 3.92 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004172 | Semaglutide | WWB | WWB-2410-D2737 | 2024-Q4 | 99.41 | 1.17 | 101.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004747 | PT-141 (Bremelanotide) | Homopeptide | HOMO-2408-P9247 | 2024-Q4 | 99.44 | 1.95 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2024-005138 | CJC-1295 (no DAC) | KP | KP-2411-Y4921 | 2024-Q4 | 99.40 | 4.04 | 106.3 | Supplier-supplied | 1 | FAIL |
| AX-2024-004911 | NAD+ | ERP | ERP-2405-P6825 | 2024-Q4 | 98.22 | 9.29 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004812 | SS-31 (Elamipretide) | Homopeptide | HOMO-2410-K1981 | 2024-Q4 | 99.93 | 3.72 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004781 | Survodutide | Homopeptide | HOMO-2406-F1206 | 2024-Q4 | 99.22 | 5.00 | 103.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004406 | Retatrutide | QSC | QSC-2408-X8779 | 2024-Q4 | 98.67 | 6.29 | 95.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005485 | Tirzepatide | BCH | BCH-2407-F6722 | 2024-Q4 | 96.93 | 5.02 | 91.3 | Buyer-sourced | 2 | FAIL |
| AX-2024-005318 | Tirzepatide | SGN | SGN-2411-N9604 | 2024-Q4 | 98.80 | 3.43 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004752 | PT-141 (Bremelanotide) | Homopeptide | HOMO-2408-P9247 | 2024-Q4 | 99.59 | 2.10 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004986 | NAD+ | GGPeps | GGPE-2405-A1540 | 2024-Q4 | 98.23 | 7.98 | 97.0 | Supplier-supplied | 0 | PASS |
| AX-2024-004250 | MK-677 (Ibutamoren mesylate) | WWB | WWB-2408-B4507 | 2024-Q4 | 99.64 | 1.54 | — | Laboratory-retained | 1 | FAIL |
| AX-2024-005326 | Tirzepatide | SGN | SGN-2408-S9172 | 2024-Q4 | 97.78 | 3.10 | 98.9 | Buyer-sourced | 1 | MARGINAL |